Cassava Sciences, Inc. Warrant
SAVAW
SAVAW was delisted on the 2nd of May, 2024.
0 hedge funds and large institutions have $0 invested in Cassava Sciences, Inc. Warrant in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
100% less funds holding
Funds holding: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $994 → $0 (-$994)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$588 |
| 2 |
MG
Mather Group
Chicago,
Illinois
|
-$403 |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
-$3 |
SAVAW Hedge Fund Activity: Q3 2024 in Review
0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cassava Sciences, Inc. Warrant (SAVAW) for Q3 2024, worth a combined $0 — down 100% from $994 a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SAVAW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Osaic Holdings, exiting entirely with an estimated $588 sold.
- 0 institutional investors held Cassava Sciences, Inc. Warrant (SAVAW) as of Q3 2024, down from 3 in Q2 2024.
- Funds reported $0 of Cassava Sciences, Inc. Warrant stock for Q3 2024, down 100% quarter-over-quarter.
- 0 funds opened new Cassava Sciences, Inc. Warrant positions in Q3 2024 and 3 closed out, a net change of -3 holders.
- The largest Cassava Sciences, Inc. Warrant seller in Q3 2024 was Osaic Holdings, an estimated $588 sold.
Based on aggregated 13F filings for Q3 2024.